戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 m disorders, substance abuse, and anxiety or somatoform disorders).
2 han the DSM-IV diagnosis of undifferentiated somatoform disorder.
3 h as sleep disorder, depression, anxiety and somatoform disorders.
4 nt a structured assessment of depressive and somatoform disorders.
5 nd sensory symptoms, functional seizures and somatoform disorders.
6  conditions (74 patients [32.2%]), suspected somatoform disorders (111 patients [48.3%]), and sexual
7 ommon current psychiatric diagnoses included somatoform disorders (89%), dissociative disorders (91%)
8 he basis of DSM-IV criteria and absence of a somatoform disorder and a plausible medical explanation.
9 stent with advancing research on anxiety and somatoform disorders and offers greater insights into th
10 osis, mania, and cluster A PDs), somatoform (somatoform disorders), and antagonism (cluster B and par
11 m posttraumatic stress disorder, depression, somatoform disorder, and malingering.
12  mood disorders, neurotic stress-related and somatoform disorders, and a range of developmental and c
13 ive, while the criteria for undifferentiated somatoform disorder are overly inclusive.
14                                              Somatoform disorders are an important determinant of med
15 t nonepileptic seizures are in a spectrum of somatoform disorders, diagnostic literature is reviewed
16 ess disorder, obsessive-compulsive disorder, somatoform disorders, eating disorders, attention-defici
17 ood disorders; neurotic, stress-related, and somatoform disorders; eating disorders; specific persona
18 line personality disorder (factors 3 and 4), somatoform disorder (factors 1 and 2), paranoid and depe
19 her anxiety disorders, eating disorders, and somatoform disorders; higher scores on most subscales of
20                                              Somatoform disorders in pediatric care are associated wi
21 CI, 1.07-1.10); anxiety, stress-related, and somatoform disorders (IRR, 1.07; 95% CI, 1.05-1.09); moo
22 ology and maintenance of somatic disease and somatoform disorders, is an important factor in the beha
23 patients, however, no conclusive features of somatoform disorder or psychogenic disorder can be found
24 asquerading as anaphylaxis, undifferentiated somatoform disorder, panic attacks, globus hystericus, v
25 t many patients fulfil strict criteria for a somatoform disorder/psychogenic dystonia.
26        Reported AUROCs for identification of somatoform disorders ranged from 0.63 (95% CI, 0.50-0.76
27 iodemographic characteristics, patients with somatoform disorder still had more primary care visits (
28 the diagnoses subsumed under the category of somatoform disorders, various nosological questions are
29                              Only 3 cases of somatoform disorders were identified, and all were assoc
30 improve both the reliability and validity of somatoform disorders will be a major challenge.